The global Artificial Hip Joint Market was valued at USD 7.66 billion in 2023 and is projected to reach USD 9.82 billion by 2031, registering a healthy CAGR of 3.6% during 2024–2031, according to SNS Insider. Market expansion is being supported by the rising incidence of hip-related disorders, an aging global population, increasing demand for mobility-enhancing procedures, and continuous advances in orthopedic implant design and materials.
The growing burden of osteoarthritis, rheumatoid arthritis, hip fractures, and other degenerative musculoskeletal conditions is increasing the need for hip replacement procedures worldwide. Older adults remain a key patient population because age-related bone and joint deterioration can significantly affect mobility and quality of life. At the same time, improvements in healthcare infrastructure and greater access to orthopedic surgery are enabling more patients to undergo joint replacement procedures.
Technological progress across implant materials, fixation methods, surgical techniques, and personalized orthopedic solutions is also reshaping the market. Manufacturers are increasingly focusing on implants designed to improve durability, stability, anatomical fit, and postoperative mobility. Developments in computer-assisted surgery, robotic-assisted procedures, and advanced preoperative planning are further supporting the adoption of modern hip replacement solutions.
Sample Request: https://www.snsinsider.com/sample-request/1009
Rising Demand for Hip Replacement Procedures Supports Market Expansion
The increasing prevalence of osteoarthritis is one of the most significant factors influencing demand for artificial hip joints. As populations age, the number of individuals experiencing cartilage deterioration, chronic joint pain, and reduced mobility is expected to rise. Hip replacement can provide an important treatment option for patients whose symptoms cannot be adequately managed through conservative therapies.
In addition, improvements in diagnostic capabilities are enabling healthcare professionals to identify joint degeneration earlier and develop appropriate treatment plans. Rising awareness regarding orthopedic treatment options is encouraging patients to seek medical intervention when persistent hip pain begins to interfere with daily activities. These factors are expected to create sustained demand for artificial hip joint systems throughout the forecast period.
Advancements in Implant Technology Improve Clinical Outcomes
Artificial hip joint manufacturers are investing in advanced materials and implant designs to address the evolving needs of patients and orthopedic surgeons. Modern implants increasingly incorporate materials engineered to provide improved wear resistance, mechanical strength, and long-term performance. Enhanced implant geometry can also help replicate natural hip biomechanics and improve stability.
The adoption of minimally invasive and robotic-assisted surgical approaches is another important development. These technologies can support greater surgical precision and more personalized implant positioning. Computer-assisted planning enables surgeons to evaluate patient anatomy before surgery and optimize procedural strategies. As hospitals continue investing in advanced orthopedic technologies, demand for technologically sophisticated hip replacement solutions is expected to increase.
Aging Population and Healthcare Access Create New Opportunities
Demographic changes represent a significant long-term opportunity for the artificial hip joint industry. The global population aged 65 and above is expanding, increasing the potential patient pool for orthopedic procedures. Longer life expectancy is also contributing to greater demand for interventions that help older adults maintain mobility and independence.
Meanwhile, healthcare systems in emerging economies are expanding access to specialized surgical services. Improvements in hospital infrastructure, physician training, insurance coverage, and healthcare spending are gradually making orthopedic procedures more accessible. Countries across Asia-Pacific and other developing regions therefore present opportunities for manufacturers seeking to expand their geographic presence.
Competitive Landscape
The artificial hip joint market remains competitive, with major orthopedic companies focusing on product innovation, strategic collaborations, geographic expansion, and advanced surgical technologies. Established manufacturers are strengthening their portfolios through implant development and investments in technologies that support precision surgery and improved patient outcomes.
Key companies profiled in the market include Johnson and Johnson, Medacta International, Stryker Corporation, B. Braun, Zimmer Biomet Holdings, MicroPort Orthopedics, Smith+Nephew, DJO Global, and Exactech. These companies compete across implant designs, materials, surgical solutions, and technology-enabled orthopedic procedures.
As competition intensifies, manufacturers are expected to prioritize personalized implants, advanced biomaterials, digital surgical planning, and robotic-assisted procedures. Product differentiation and the ability to provide comprehensive orthopedic solutions will remain important competitive factors.
Future Outlook
The artificial hip joint market is positioned for steady growth through 2031 as demographic trends, disease prevalence, healthcare accessibility, and technological advancements converge. Increasing emphasis on restoring mobility and improving quality of life is expected to sustain demand for hip replacement procedures.
At the same time, ongoing research into implant materials, fixation technologies, surgical navigation, and patient-specific solutions could create new avenues for market development. As healthcare providers increasingly adopt precision-oriented orthopedic technologies, manufacturers capable of combining durable implant performance with advanced surgical support are likely to remain well positioned.
With the market expected to increase from USD 7.66 billion in 2023 to USD 9.82 billion by 2031, the artificial hip joint industry will continue to represent an important segment of the global orthopedic devices landscape.